Newhub 15 April

A breakthrough drug used to treat a form of Hodgkin's lymphoma will dramatically drop in price from May.

Keytruda, an immunotherapy drug, will now be listed by the Australian federal government on the Pharmaceutical Benefits Scheme (PBS). Read More